Nuwellis Inc NUWE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NUWE is a good fit for your portfolio.
News
-
Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health
-
Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics Conference
-
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
-
Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024
-
Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™
-
Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics Conference
-
New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload
Trading Information
- Previous Close Price
- $0.25
- Day Range
- $0.25–0.40
- 52-Week Range
- $0.24–5.73
- Bid/Ask
- $0.28 / $0.30
- Market Cap
- $1.97 Mil
- Volume/Avg
- 9.9 Mil / 1.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.06
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 59
- Website
- https://www.nuwellis.com
Valuation
|
Metric
|
NUWE
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.48 |
Price/Sales | 0.06 |
Price/Cash Flow | — |
Price/Earnings
NUWE
Financial Strength
|
Metric
|
NUWE
|
|---|---|
Quick Ratio | 1.81 |
Current Ratio | 2.59 |
Interest Coverage | −4.80 |
Quick Ratio
NUWE
Profitability
|
Metric
|
NUWE
|
|---|---|
Return on Assets (Normalized) | −127.21% |
Return on Equity (Normalized) | −212.11% |
Return on Invested Capital (Normalized) | −167.37% |
Return on Assets
NUWE
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Dfrlqdy | Lrxkfc | $185.5 Bil | |
SYK
| Stryker Corp | Xffndpfb | Xbwp | $128.2 Bil | |
MDT
| Medtronic PLC | Kkhykwlg | Kvmyyp | $106.7 Bil | |
BSX
| Boston Scientific Corp | Fwnkjlbp | Rkltyz | $99.0 Bil | |
DXCM
| DexCom Inc | Pxklylzpsd | Hgrn | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Ckghwlngm | Vffnbw | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qmbsjlmq | Stl | $24.9 Bil | |
ALGN
| Align Technology Inc | Yhcrjgm | Xglbwg | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Fwqxvjt | Kszrwq | $18.9 Bil | |
PODD
| Insulet Corp | Bzzrnlbz | Wnlxn | $11.7 Bil |